| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
1 Program in Molecular Biology and Human Genetics, Karmanos Cancer Institute, Department of Pathology, Wayne State University School of Medicine, Detroit, Michigan and 2 Children's Research Institute, Department of Pediatrics, The Ohio State University, Columbus, Ohio
Requests for reprints: Gen Sheng Wu, Program in Molecular Biology and Human Genetics, Karmanos Cancer Institute, Department of Pathology, Wayne State University School of Medicine, Room E216, 110 East Warren Avenue, Detroit, MI 48201. Phone: 313-833-0715, ext. 2328; Fax: 313-831-7518; E-mail: wug{at}karmanos.org.
Mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) is a member of the MAPK phosphatase family that functions as a negative regulator of MAPK signaling. MKP-1 is induced by oxidative stress, but the role of its induction in cell death is not fully understood. Here, we show that hydrogen peroxide (H2O2) induces MKP-1 and activates MAPKs. Induction of MKP-1 by H2O2 correlated with inactivation of p38 and c-Jun-NH2-kinase (JNK). Overexpression of MKP-1 increased cell resistance to H2O2-induced death. Furthermore, we show by small interfering RNA silencing that down-regulation of MKP-1 increases phosphorylated p38 and JNK and subsequent cell death induced by H2O2. More importantly, primary embryonic fibroblasts from mice lacking MKP-1 had a higher level of phosphorylated p38 and JNK and were more sensitive to H2O2-induced cell death compared with corresponding cells with MKP-1, indicating that p38 and JNK pathways may play important roles in H2O2-mediated cell death. Thus, these results suggest that activation of MKP-1 is a survival mechanism against oxidative damage. (Cancer Res 2006; 66(9): 4888-94)
This article has been cited by other articles:
![]() |
R. Liu, H.-Q. Zheng, Z. Zhou, J.-T. Dong, and C. Chen KLF5 Promotes Breast Cell Survival Partially through Fibroblast Growth Factor-binding Protein 1-pERK-mediated Dual Specificity MKP-1 Protein Phosphorylation and Stabilization J. Biol. Chem., June 19, 2009; 284(25): 16791 - 16798. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shenoy, Y. Wu, and S. Pervaiz LY303511 Enhances TRAIL Sensitivity of SHEP-1 Neuroblastoma Cells via Hydrogen Peroxide-Mediated Mitogen-Activated Protein Kinase Activation and Up-regulation of Death Receptors Cancer Res., March 1, 2009; 69(5): 1941 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Xie, S. Guo, Y. Fan, H. Zhang, D. Gu, and H. Li Atrogin-1/MAFbx Enhances Simulated Ischemia/Reperfusion-induced Apoptosis in Cardiomyocytes through Degradation of MAPK Phosphatase-1 and Sustained JNK Activation J. Biol. Chem., February 27, 2009; 284(9): 5488 - 5496. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Beck, J. Verrax, N. Dejeans, H. Taper, and P. B. Calderon Menadione Reduction by Pharmacological Doses of Ascorbate Induces an Oxidative Stress That Kills Breast Cancer Cells International Journal of Toxicology, January 1, 2009; 28(1): 33 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Arnoldussen, P. I. Lorenzo, M. E. Pretorius, H. Waehre, B. Risberg, G. M. Maelandsmo, H. E. Danielsen, and F. Saatcioglu The Mitogen-Activated Protein Kinase Phosphatase Vaccinia H1-Related Protein Inhibits Apoptosis in Prostate Cancer Cells and Is Overexpressed in Prostate Cancer Cancer Res., November 15, 2008; 68(22): 9255 - 9264. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chiloeches, A. Sanchez-Pacheco, B. Gil-Araujo, A. Aranda, and M. Lasa Thyroid Hormone-Mediated Activation of the ERK/Dual Specificity Phosphatase 1 Pathway Augments the Apoptosis of GH4C1 Cells by Down-Regulating Nuclear Factor-{kappa}B Activity Mol. Endocrinol., November 1, 2008; 22(11): 2466 - 2480. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hou, S. Torii, N. Saito, M. Hosaka, and T. Takeuchi Reactive Oxygen Species-Mediated Pancreatic {beta}-Cell Death Is Regulated by Interactions between Stress-Activated Protein Kinases, p38 and c-Jun N-Terminal Kinase, and Mitogen-Activated Protein Kinase Phosphatases Endocrinology, April 1, 2008; 149(4): 1654 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, J.-Y. Zhou, and G. S. Wu ERK-Dependent MKP-1 Mediated Cisplatin Resistance in Human Ovarian Cancer Cells Cancer Res., December 15, 2007; 67(24): 11933 - 11941. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, J. Xu, J.-Y. Zhou, Y. Liu, and G. S. Wu Mitogen-Activated Protein Kinase Phosphatase-1 Is Required for Cisplatin Resistance. Cancer Res., September 1, 2006; 66(17): 8870 - 8877. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |